Rinomaris spray 0.1% 15ml

Instruction for Rinomaris

Reed more and buy Rinomaris here

Description of the drug

Rinomaris is available with the active substance xylometazoline, which is an alpha-adrenostimulator. The substance according to the chemical formula is similar to naphazoline. The drug affects the circulatory system in the nasal passage and has a decongestant effect with the removal of hyperemia of the nasal passage. Effective in various forms of rhinitis or other nasal diseases. Continuous use can be addictive and the effectiveness of the drug is significantly reduced. The drug begins to act after a short period of time and has an effect on the mucous membranes for several hours. Also, according to the reviews of the drug, rinomaris can be addictive or similar. Rinomaris is not recommended during pregnancy.

Release form, composition and packaging

The drug is available in the form of a nasal spray. The composition of the drug includes: • xylometazoline; • potassium salt of phosphoric acid; • purified liquid; • sea water (Adriatic Sea). The medicine is available in soft packaging with a nozzle. The bottle is placed in a cardboard box. In the box: 1 bottle with a nozzle and instructions for use. Be sure to check the availability of the drug in the bottle. You can buy Rinomaris in a pharmacy on our website. Carefully study the indications for use, since the drug is not used in some inflammatory processes.

pharmachologic effect

The drug is not exposed to absorbing effects and has virtually no effect on the body in general. The active substance in the plasma has a very low level, which is not possible to determine with modern medical solutions. Xylometazoline is an alpha-adrenostimulator, which helps to reduce blood vessels and relieve inflammatory processes in the mucous membranes of the nasal membranes. The drug is used to relieve swelling and hyperemia of the nasal passage. Due to the specific effect on the tissues in the nose, it is used for acute and simple forms of rhinitis. At the recommended dosage, it does not irritate the mucous membrane and does not exacerbate inflammation of the nasal tissues. Proper use leads to a quick relief of the symptoms of rhinitis. The therapeutic effect lasts 12 hours. The water of the Adriatic Sea has a calming effect on the mucous membranes, and also contributes to the normal functioning of the entire nasal system. Due to sea water, the accumulated mucus is diluted and its production in muconasal organs is normalized. The combined effect of all components improves the general condition, and also prevents possible side effects in the form of dry mucous membranes and irritation of the epithelium inside the nose.

Indications

Indications of the drug rinomaris are completely associated with obstruction or inflammatory reactions in the nasal passage. What the drug helps from: • inflammation of the mucous membrane of one or more sinuses; • seasonal disease amid allergic reactions to pollen; • various forms of the syndrome of inflammation of the nasal mucosa; • localized inflammation in the Eustachian tube; • inflammatory disease of the middle ear. In medical institutions, it is often used as a preliminary treatment in case of diagnosis in the nasal passages.

Contraindications

The drug has several contraindications: • individual intolerance to any component of the drug; • persistent increase in blood pressure; • increase in heart rate; • a pronounced form of chronic disease of the arteries of elastic and muscular-elastic type; • a group of eye diseases characterized by a constant or periodic increase in intraocular pressure; • chronic inflammatory damage to the nasal mucosa; • a syndrome associated with excessive formation of thyroid hormones; • brain surgery; • children under 2 years of age (0.05% solution); • children under 6 years of age (0.1% solution). If a preliminary history of diabetes mellitus or chest pain is present, the drug should be previously agreed with your doctor.

Dosage

It is not recommended to use the drug for more than one week, as this can cause addiction or worsening of the mucous membranes. Children under 2 years of age are treated with a solution of 0.05%, 1 injection from a bottle into each nasal passage twice a day. Children from 2 to 6 years old using a 0.1% solution: 1 injection from the vial twice a day into each nasal passage. Children over 6 years old and adults: 1 injection from the bottle into each nasal passage 2-3 times a day. It is not recommended to use rinomaris more than 3 times a day.

Overdose

In the case of prolonged use or excessive spraying in the nose of rinomaris, the risk of adverse reactions with increased effect increases. In case of any symptoms after excessive use of the drug, discontinue treatment and consult a specialist.

Drug interaction

Rinomaris is not recommended for use with the following drugs, because of critical compatibility indicators: • drugs including monoamine oxidase inhibitors; • drugs with tricyclic antidepressant functionality. Notify your doctor before taking rinomaris about any medications you are taking, as not all manufacturers provide a complete list of active substances.

special instructions

Rinomaris should not be used for persons who drive vehicles or require a high concentration of attention during work. The active substance may cause temporary inhibition of the reaction. The use of rinomaris is determined by the preliminary cleaning of the nasal passages, since the active substance may not reach the final goal of exposure. Do not use the drug as a permanent treatment, it can be addictive or worsen. It is forbidden to use the drug for chronic diseases of rhinitis.

Pregnancy and lactation

There was no adequate and well-controlled study in pregnant women. Using the drug during pregnancy is not recommended unless the benefits outweigh the risks. Although the concentration of the active substance in the blood is low, it is not known whether xylometazoline crosses the placenta. However, low molecular weight and minimal protein binding to the drug suggest that human placenta transfer is likely. Patients should notify their doctor if they become pregnant or intend to become pregnant during treatment with the drug. The effects of the drug during childbirth are unknown. According to the manufacturer, caution should be exercised when prescribing the drug during breastfeeding. Pumping or pumping breast milk and discarding it within a few hours after the dose is administered will help avoid maximum exposure to xylometazoline in infants. Think about the benefits of breastfeeding, the risk of potential exposure to xylometazoline in your baby, and the risk of no treatment or inappropriate treatment.

Side effects

Rinomaris has a number of side effects: • depression; • irritation of the mucous membranes; • arrhythmia; • severe swelling in the nasal passage; • visual impairment; • tingling in the nose; • tachycardia; • increased synthesis of mucus; • heart palpitations; • burning sensation in the nose; • migraine; • dryness; • insomnia; • increase in blood pressure; • gagging. In case of any of the above side effects, stop taking rinomaris and consult your doctor for further instructions. Do not continue treatment without prior approval from a doctor. It is not recommended to use analogues of rinomaris at the same time, as this will lead to pronounced adverse reactions.

Use in childhood

The use of rinomaris in childhood is confirmed and applied according to the indicated dosage. How to take the drug? Follow the instructions for use and the instructions of the doctor during the use of the drug in children of different ages. In case of any changes after injection, it is necessary to contact a medical institution.

Terms and conditions of storage

Do not expose rinomaris to direct sunlight. Temperature condition no more than + 25 degrees. In Moscow, the medicine is dispensed without a prescription.

Terms of sell

You can buy Rinomaris without a prescription.